137 related articles for article (PubMed ID: 23360313)
1. Motivators to participation in medical trials: the application of social and personal categorization.
Dhalla S; Poole G
Psychol Health Med; 2013; 18(6):664-75. PubMed ID: 23360313
[TBL] [Abstract][Full Text] [Related]
2. Motivators of enrolment in HIV vaccine trials: a review of HIV vaccine preparedness studies.
Dhalla S; Poole G
AIDS Care; 2011 Nov; 23(11):1430-47. PubMed ID: 21722022
[TBL] [Abstract][Full Text] [Related]
3. Motivators to participation in actual HIV vaccine trials.
Dhalla S; Poole G
AIDS Behav; 2014 Feb; 18(2):263-77. PubMed ID: 23736885
[TBL] [Abstract][Full Text] [Related]
4. Volunteer motivators for participating in HIV vaccine clinical trials in Nairobi, Kenya.
Nyaoke BA; Mutua GN; Sajabi R; Nyasani D; Mureithi MW; Anzala OA
PLoS One; 2017; 12(9):e0183788. PubMed ID: 28880880
[TBL] [Abstract][Full Text] [Related]
5. The decision to enroll in HIV vaccine efficacy trials: concerns elicited from gay men at increased risk for HIV infection.
MacQueen KM; Buchbinder S; Douglas JM; Judson FN; McKirnan DJ; Bartholow B
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S261-4. PubMed ID: 7865314
[No Abstract] [Full Text] [Related]
6. HIV vaccine trial preparedness among Spanish-speaking Latinos in the US.
Brooks RA; Newman PA; Duan N; Ortiz DJ
AIDS Care; 2007 Jan; 19(1):52-8. PubMed ID: 17129857
[TBL] [Abstract][Full Text] [Related]
7. Altruism motivates participation in a therapeutic HIV vaccine trial (CTN 173).
Balfour L; Corace K; Tasca GA; Tremblay C; Routy JP; Angel JB
AIDS Care; 2010 Nov; 22(11):1403-9. PubMed ID: 20936540
[TBL] [Abstract][Full Text] [Related]
8. Selectively willing and conditionally able: HIV vaccine trial participation among women at "high risk" of HIV infection.
Voytek CD; Jones KT; Metzger DS
Vaccine; 2011 Aug; 29(36):6130-5. PubMed ID: 21704110
[TBL] [Abstract][Full Text] [Related]
9. Contextualizing willingness to participate: recommendations for engagement, recruitment & enrolment of Kenyan MSM in future HIV prevention trials.
Doshi M; Avery L; Kaddu RP; Gichuhi M; Gakii G; du Plessis E; Dutta S; Khan S; Kimani J; Lorway RR
BMC Public Health; 2017 May; 17(1):469. PubMed ID: 28521748
[TBL] [Abstract][Full Text] [Related]
10. Typologies of Altruistic and Financial Motivations for Research Participation.
Chin LJ; Berenson JA; Klitzman RL
J Empir Res Hum Res Ethics; 2016 Oct; 11(4):299-310. PubMed ID: 28251864
[TBL] [Abstract][Full Text] [Related]
11. Participation in two phase II prophylactic HIV vaccine trials in the UK.
Gray K; Legg K; Sharp A; Mackie N; Olarinde F; De Souza C; Weber J; Peters B
Vaccine; 2008 Jun; 26(23):2919-24. PubMed ID: 18450339
[TBL] [Abstract][Full Text] [Related]
12. Barriers of enrolment in HIV vaccine trials: a review of HIV vaccine preparedness studies.
Dhalla S; Poole G
Vaccine; 2011 Aug; 29(35):5850-9. PubMed ID: 21740947
[TBL] [Abstract][Full Text] [Related]
13. Motivations to participate in a Phase I/II HIV vaccine trial: A descriptive study from Dar es Salaam, Tanzania.
Tarimo EA; Bakari M; Kakoko DC; Kohi TW; Mhalu F; Sandstrom E; Kulane A
BMC Public Health; 2016 Feb; 16():182. PubMed ID: 26911203
[TBL] [Abstract][Full Text] [Related]
14. HIV vaccine trial participation among ethnic minority communities: barriers, motivators, and implications for recruitment.
Newman PA; Duan N; Roberts KJ; Seiden D; Rudy ET; Swendeman D; Popova S
J Acquir Immune Defic Syndr; 2006 Feb; 41(2):210-7. PubMed ID: 16394854
[TBL] [Abstract][Full Text] [Related]
15. [The psychosocial approach to the planning and implementation of vaccine trials for HIV infection].
Starace F; Embrione F; Fusco ML; Cafaro L
Ann Ist Super Sanita; 2003; 39(2):259-66. PubMed ID: 14587226
[TBL] [Abstract][Full Text] [Related]
16. Participation of homosexual/bisexual men in preventive HIV vaccine trials: baseline attitudes and concerns and predicted behaviors during trials.
Douglas JM; Judson FN; Parks JP; Buchbinder S; McKirnan D
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S257-60. PubMed ID: 7865313
[No Abstract] [Full Text] [Related]
17. Social and behavioral aspects of child and adolescent participation in HIV vaccine trials.
Swartz L; Kagee A; Kafaar Z; Smit J; Bhana A; Gray G; Lesch A; Lindegger G; Milford C; Richter L; Seedat S; Skhosana N; Stein DJ
J Int Assoc Physicians AIDS Care (Chic); 2005 Dec; 4(4):89-92. PubMed ID: 16533797
[TBL] [Abstract][Full Text] [Related]
18. Required HIV antibody testing, social risk, and HIV-vaccine efficacy trials.
MacQueen KM; Buchbinder SP; Douglas JM; Judson FN; McKirnan DJ; Bartholow BN
AIDS Public Policy J; 1996; 11(2):104-12. PubMed ID: 10915243
[No Abstract] [Full Text] [Related]
19. Behavioral research contributions to planning and conducting HIV vaccine efficacy studies.
Temoshok LR
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S277-80. PubMed ID: 7865318
[No Abstract] [Full Text] [Related]
20. Social impact of preventive HIV vaccine clinical trial participation: a model of prevention, assessment and intervention.
Allen M; Lau CY
Soc Sci Med; 2008 Feb; 66(4):945-51. PubMed ID: 18162272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
